Kardigan
South San Francisco, California, United States · Biotechnology, Health Care, research · 120 employees
Kardigan is a patient-driven heart health company that is modernizing cardiovascular drug development to deliver medicines that move patients beyond symptom management to functional cures. By matching critical disease drivers with treatment responders identified in clinical trials, Kardigan is developing a portfolio of medicines that modify the underlying cardiovascular disease pathophysiology to
Funding history
- Series B — $254.0M — Oct 2025
- Series A — $300.0M — Jan 2025
Recent signals
- Oct 14, 2025: Raised $254.0M in Series B
- Jan 10, 2025: Raised $300.0M in Series A
See plans & pricing → Track Kardigan’s funding, hiring, and signals — with verified contacts — on Fundz.